A new orally active antitumor 1R,2R-cyclohexanediamine-platinum(IV) complex: trans-(n-valerato)chloro(1R,2R-cyclohexanediamine) (oxalato)platinum(IV) R. KizuTakeo NakanishiY. Kidani ORIGINAL ARTICLE Pages: 97 - 105
A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer Michael A. StellerMerrill J. EgorinRobert L. Dedrick ORIGINAL ARTICLE Pages: 106 - 114
In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines Margaret M. WagnerDonald C. PaulD. C. Williams ORIGINAL ARTICLE Pages: 115 - 125
Pharmacokinetics of dolasetron with coadministration of cimetidine or rifampin in healthy subjects Dan C. DimmittMichael B. CramerScott J. Weir ORIGINAL ARTICLE Pages: 126 - 132
Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens Federico InnocentiRomano DanesiM. Del Tacca ORIGINAL ARTICLE Pages: 133 - 140
A phase I study of recombinant human soluble interleukin-1 receptor (rhu IL-1R) in patients with relapsed and refractory acute myeloid leukemia Steven H. BernsteinJoseph FayGeoffrey Herzig ORIGINAL ARTICLE Pages: 141 - 144
Activity of fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines Gregory P. KalemkerianXiaolan Ou ORIGINAL ARTICLE Pages: 145 - 150
Protection against doxorubicin-induced cardiotoxicity in weanling rats by dexrazoxane Paola Della TorreG. MazuéA. R. Imondi ORIGINAL ARTICLE Pages: 151 - 156
Failure of oral nitrate and calcium channel blocker therapy to prevent 5-fluorouracil-related myocardial ischemia: a case report Gorgun AkpekK. L. Hartshorn ORIGINAL ARTICLE Pages: 157 - 161
Phase II study of CI-958 in colorectal cancer Anthony F. ShieldsPhilip A. PhilipMark M. Zalupski ORIGINAL ARTICLE Pages: 162 - 164
Lack of correlation between mitotic arrest or apoptosis and antitumor effect of docetaxel Ronald SchimmingKathryn A. MasonL. Milas ORIGINAL ARTICLE Pages: 165 - 172
The venotonic drug hydroxyethylrutosiden does not prevent or reduce docetaxel-induced fluid retention: results of a comparative study L. C. PronkW. L. J. van PuttenJ. Verweij CLINICAL TRIAL REPORT Pages: 173 - 177
Safety and potential effectiveness of daunorubicin-containing liposomes in patients with advanced recurrent malignant CNS tumors A. BoiardiAnnalisa PozziAntonio Silvani CLINICAL TRIAL REPORT Pages: 178 - 179
Vinorelbine-related acute cardiopulmonary toxicity Nataly KarminskyOfer MerimskyMoshe Inbar SHORT COMMUNICATION Pages: 180 - 182